Regeneron Pharmaceuticals, one of the largest biotechnology companies, and gene therapy upstart Bluebird Bio will team up to invent genetically modified white blood cells that can attack cancer.
Category: NASDAQ:BLUE
Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer
Regeneron Pharmaceuticals, one of the largest biotechnology companies, and gene therapy upstart Bluebird Bio will team up to invent genetically modified white blood cells that can attack cancer.
Bluebird Bio Gene Therapies Show Promise Against Deadly Anemias
Bluebird Bio’s experimental gene therapy LentiGlobin is helping some patients with two life-threatening forms of inherited anemia avoid blood transfusions.
